Apimeds Pharmaceuticals US, Inc. (APUS) SEC filings
APUS SEC filings moved a median of +0.23% by the close. APUS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the APUS overview →
50 measured APUS SEC filing events.
Where these APUS SEC filings landedvs 34 measured APUS SEC filing reactions
| Middle 50% of APUS SEC filing reactions | -2.01% to +2.94% |
|---|---|
| Median reaction (to close) | +0.23% |
| Measured reactions | 34 |
Point-in-time · zero look-ahead
Half of the 34 APUS SEC filing events with a measured close landed between -2.01% and +2.94%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Apimeds Pharmaceuticals For: Oct 04 | SEC filing · Form 8-K | -5.34% | -5.13% | |
| Form 8-K Apimeds Pharmaceuticals For: Sep 29 | SEC filing · Form 8-K | +1.22% | -16.33% | |
| Form 8-K Apimeds Pharmaceuticals For: Sep 24 | SEC filing · Form 8-K | -3.77% | -0.79% | |
| Form 8-K Apimeds Pharmaceuticals For: Jul 24 | SEC filing · Form 8-K | -1.10% | +26.52% | |
| Form 8-K Apimeds Pharmaceuticals For: Sep 10 | SEC filing · Form 8-K | -1.62% | -2.55% | |
| Form 8-K Apimeds Pharmaceuticals For: Aug 19 | SEC filing · Form 8-K | +0.00% | +9.45% | |
| Form 10-Q Apimeds Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +4.35% | +24.06% | |
| Form 8-K Apimeds Pharmaceuticals For: Aug 05 | SEC filing · Form 8-K | +0.42% | -10.57% | |
| Form 8-K Apimeds Pharmaceuticals For: Jul 13 | SEC filing · Form 8-K | +1.25% | +1.58% | |
| Form 10-Q Apimeds Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +6.34% | +0.00% | |
| Form NT 10-Q Apimeds Pharmaceuticals For: Mar 31 | SEC filing · Form NT | +0.00% | -1.32% | |
| Form 8-K Apimeds Pharmaceuticals For: May 05 | SEC filing · Form 8-K | +0.00% | +57.90% | |
| Form 10-K Apimeds Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 8-K Apimeds Pharmaceuticals For: Apr 24 | SEC filing · Form 8-K | — | — | |
| Form 8-K Apimeds Pharmaceuticals For: Apr 17 | SEC filing · Form 8-K | — | — | |
| Form 8-K Apimeds Pharmaceuticals For: Apr 15 | SEC filing · Form 8-K | — | — | |
| Form 8-K/A Apimeds Pharmaceuticals For: Mar 20 | SEC filing · Form 8-K | — | — | |
| Form NT 10-K Apimeds Pharmaceuticals For: Dec 31 | SEC filing · Form NT | — | -2.23% | |
| Form 8-K Apimeds Pharmaceuticals For: Mar 20 | SEC filing · Form 8-K | — | +17.90% | |
| Form 8-K Apimeds Pharmaceuticals For: Mar 20 | SEC filing · Form 8-K | +0.00% | +0.57% | |
| Form 8-K Apimeds Pharmaceuticals For: Mar 16 | SEC filing · Form 8-K | +3.85% | +3.11% | |
| Form DEFM14C Apimeds Pharmaceuticals | SEC filing · Form DEFM14C | — | +2.26% | |
| Form 8-K/A Apimeds Pharmaceuticals For: Dec 01 | SEC filing · Form 8-K | +1.23% | +4.10% | |
| Form PREM14C Apimeds Pharmaceuticals For: Jan 16 | SEC filing · Form PREM14C | +0.00% | +2.44% | |
| Form 8-K Apimeds Pharmaceuticals For: Dec 30 | SEC filing · Form 8-K | +4.19% | +10.78% | |
| Form 8-K Apimeds Pharmaceuticals For: Dec 05 | SEC filing · Form 8-K | +2.29% | -3.67% | |
| Form 8-K/A Apimeds Pharmaceuticals For: Dec 01 | SEC filing · Form 8-K | +2.29% | -3.67% | |
| Form 8-K Apimeds Pharmaceuticals For: Dec 01 | SEC filing · Form 8-K | -2.74% | +0.46% | |
| Form 8-K Apimeds Pharmaceuticals For: Nov 13 | SEC filing · Form 8-K | +0.00% | -0.66% | |
| Form 10-Q Apimeds Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -1.83% | — | |
| Form 8-K Apimeds Pharmaceuticals For: Oct 15 | SEC filing · Form 8-K | +3.23% | -1.07% | |
| Form 10-Q Apimeds Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -4.23% | |
| Form NT 10-Q Apimeds Pharmaceuticals For: Jun 30 | SEC filing · Form NT | — | -0.62% | |
| Form 8-K Apimeds Pharmaceuticals For: Jul 15 | SEC filing · Form 8-K | +3.37% | +1.12% | |
| Form 8-K Apimeds Pharmaceuticals For: May 30 | SEC filing · Form 8-K | -0.54% | +4.32% | |
| Form S-8 Apimeds Pharmaceuticals | SEC filing · Form S-8 | +0.00% | -1.10% | |
| Form 10-Q Apimeds Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -1.66% | +2.21% | |
| Form 8-K Apimeds Pharmaceuticals For: May 16 | SEC filing · Form 8-K | -1.66% | +2.21% | |
| Form NT 10-Q Apimeds Pharmaceuticals For: Mar 31 | SEC filing · Form NT | +5.23% | -1.16% | |
| Form 8-K Apimeds Pharmaceuticals For: May 08 | SEC filing · Form 8-K | -3.31% | -3.31% | |
| Form EFFECT Apimeds Pharmaceuticals | SEC filing · Form EFFECT | — | — | |
| Form 10-K/A Apimeds Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form POS AM Apimeds Pharmaceuticals | SEC filing · Form POS | — | — | |
| Form POS AM Apimeds Pharmaceuticals | SEC filing · Form POS | — | — | |
| Form POS AM Apimeds Pharmaceuticals | SEC filing · Form POS | — | — | |
| Form 10-K Apimeds Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 8-K Apimeds Pharmaceuticals For: Apr 11 | SEC filing · Form 8-K | — | — | |
| Form NT 10-K Apimeds Pharmaceuticals For: Dec 31 | SEC filing · Form NT | — | — | |
| Form CERT Apimeds Pharmaceuticals | SEC filing · Form CERT | — | — | |
| Form 8-A12B Apimeds Pharmaceuticals | SEC filing · Form 8-A12B | — | — |
Keep exploring
More APUS: earnings → · analyst actions → · APUS overview →